Matchpoint Therapeutics is a stealth-mode drug discovery company designing a new generation of precision covalent medicines informed by breakthroughs in ultradeep chemoproteomics and machine learning. Our discovery platform enables the design of highly selective medicines that unleash the full power of covalency towards both well validated but difficult to drug targets, and novel targets uncovered to be drivers of cancer and severe immunological disorders.

We are rapidly growing our team and looking for passionate, driven, and creative thinkers to join us in ushering in a new era of covalent medicines.